JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, G.
Right arrow Articles by Kalivas, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, G.
Right arrow Articles by Kalivas, P. W.

Vol. 289, Issue 1, 412-416, April 1999

The Regulation of Dopamine Transmission by Metabotropic Glutamate Receptors1

Gang Hu, Patricia Duffy, Chad Swanson, M. Behnam Ghasemzadeh and Peter W. Kalivas

Department of Physiology and Neuroscience, Medical University of South Carolina, Charleston, South Carolina

Receptor subtype nonselective metabotropic glutamate receptor (mGluR) agonists have been shown to regulate the release of dopamine. The eight mGluR subtypes have been pharmacologically categorized into three groups, and the present study used in vivo microdialysis to examine the capacity of mGluR subgroup-selective drugs to modulate the extracellular levels of dopamine in the nucleus accumbens. By administering the drugs in the dialysis buffer, it was found that the group 3 mGluR agonist L-amino-4-phosphonobutyrate produced a dose-dependent reduction in extracellular dopamine, whereas the group 1 agonist 3,5-dihydroxyphenylglycine was ineffective. The group 2 agonist (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine produced a reduction that was biphasic with respect to dose. The group 2/3 antagonist alpha -methyl-4-phosphnophenylglycine elicited a dose-dependent increase in extracellular dopamine that was antagonized by coperfusion with either the L-type calcium channel blocker diltiazem or the group 3 agonist L-amino-4-phosphonobutyrate. These data demonstrate that group 3 and to a lesser extent group 2 mGluR may presynaptically regulate dopamine release or reuptake. Moreover, there exists significant in vivo glutamatergic tone on group 2/3 mGluRs to suppress extracellular dopamine levels.

0022-3565/99/2891-0412$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
A. Madayag, D. Lobner, K. S. Kau, J. R. Mantsch, O. Abdulhameed, M. Hearing, M. D. Grier, and D. A. Baker
Repeated N-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine
J. Neurosci., December 19, 2007; 27(51): 13968 - 13976.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. E. Liechti, L. Lhuillier, K. Kaupmann, and A. Markou
Metabotropic Glutamate 2/3 Receptors in the Ventral Tegmental Area and the Nucleus Accumbens Shell Are Involved in Behaviors Relating to Nicotine Dependence
J. Neurosci., August 22, 2007; 27(34): 9077 - 9085.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. S. Adewale, D. M. Platt, and R. D. Spealman
Pharmacological Stimulation of Group II Metabotropic Glutamate Receptors Reduces Cocaine Self-Administration and Cocaine-Induced Reinstatement of Drug Seeking in Squirrel Monkeys
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 922 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Morishima, T. Miyakawa, T. Furuyashiki, Y. Tanaka, H. Mizuma, and S. Nakanishi
Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice
PNAS, March 15, 2005; 102(11): 4170 - 4175.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. A. Baker, Z.-X. Xi, H. Shen, C. J. Swanson, and P. W. Kalivas
The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate
J. Neurosci., October 15, 2002; 22(20): 9134 - 9141.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Z.-X. Xi, D. A. Baker, H. Shen, D. S. Carson, and P. W. Kalivas
Group II Metabotropic Glutamate Receptors Modulate Extracellular Glutamate in the Nucleus Accumbens
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 162 - 171.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
V. Neugebauer, P.-S. Chen, and W. D. Willis
Groups II and III Metabotropic Glutamate Receptors Differentially Modulate Brief and Prolonged Nociception in Primate STT Cells
J Neurophysiol, December 1, 2000; 84(6): 2998 - 3009.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.